Home
About SinovacProductsPipelineInvestorsContact Us
 
 
  SITEMAP 中文版
  Investors
IR Home
President Message
Corporate Governance
Social Responsibility
Press Releases
Media Report
Earnings Releases
Analyst Coverage
FAQs
Home Page
 
 
Sinovac to Host Conference Call to Report Second Quarter 2008 Financial Results

Sinovac to Host Conference Call to Report Second Quarter 2008 Financial Results
Thursday August 7, 8:00 am ET

 

BEIJING, Aug. 7 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA - News), a vaccine-focused biotech company in China, today announced that it will host a conference call on Wednesday, August 13, 2008 at 9:00 a.m. ET to review the Company's second quarter financial results for the period ended June 30, 2008 and provide an update on recent corporate developments.

 

To access the conference call, please dial 1-877-407-4018 ( ) or 1-201- 689-8471 (international). A replay of the call will be available from 12:00 p.m. ET on August 13 until August 27, 2008, at midnight. To access the replay, please dial 1-877-660-6853 ( ) or 1-201-612-7415 (international) and reference the account number 3055 and the access code 293426.

 

A live audio webcast of the call will also be available from the Investors section on the corporate web site at http://www.sinovac.com . A webcast replay can be accessed on the corporate website beginning August 13, 2008 and the replay will remain available for 30 days.

 

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's commercialized vaccines include Healive® (hepatitis A), Bilive® (combined hepatitis A and B), Anflu® (influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional information about Sinovac is available on its website, http://www.sinovac.com . To be added to our distribution list, please email: info@sinovac.com.

  

 For more information, please contact:

 

     Helen G. Yang

     Sinovac Biotech Ltd.

     Tel:   +86-10-8289-0088 x871

     Fax:   +86-10-6296-6910

     Email: info@sinovac.com

 

    Investors/Media:

 

     Stephanie Carrington

     The Ruth Group

     Tel:   +1-646-536-7017

     Email: scarrington@theruthgroup.com

 

     Janine McCargo

     The Ruth Group

     Tel:   +1-646-536-7033

     Email: jmccargo@theruthgroup.com



Original:本站原创
Click Volume:
 
 
Copyright © 2001-2008 Sinovac Biotech Ltd. All rights reserved.